"ProtocolName","LabelName","GroupValues","Size","Estimator","RMSE","Correlation","IC50","MAE"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Weka RF folded fingerprints regression","0.8446286910511891","0.7924350555950698","yes","0.6339534269822559"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","RBF libSVM folded fingerprints regression","0.9142519670620749","0.7634752947163894","yes","0.6526094195456099"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Tanimoto Smile SVM regression","0.9093042519663274","0.7633692025160546","yes","0.6714320933148971"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Poly Smile SVM fingerprints regression","0.9180463664925429","0.7590009427279814","yes","0.6710098957849859"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Weka RF descriptors regression","0.933354584199872","0.7387158668625955","yes","0.7447457339897738"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","Elastic Net on folded fingerprints regression","1.0080974034551347","0.7109826162610372","yes","0.7484948041342422"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2/Cyclin A|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","171","RBF Smile SVM descriptors regression","1.0240384537516907","0.703962046923421","yes","0.7728224157175939"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","RBF libSVM folded fingerprints regression","0.8408489004237925","0.8134706859922671","yes","0.6164714885091312"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Poly Smile SVM fingerprints regression","0.8482594365721997","0.809334900860261","yes","0.6300228981145648"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Tanimoto Smile SVM regression","0.8537250672463569","0.8070180660077347","yes","0.6292027784757421"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Weka RF folded fingerprints regression","0.8661584486579873","0.8040099137330018","yes","0.6614210966191495"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","RBF Smile SVM descriptors regression","0.8656363700410061","0.8034588746536631","yes","0.6380936677977099"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Elastic Net on folded fingerprints regression","0.8764837463062846","0.7955307423250593","yes","0.6419071972748482"
"CDK2","Activity Value","Assay Description:Inhibition of CDK2|Activity Type:IC50|Target Accession Numbers:NP_001789, SK067, P24941|Standard Unit:nM","412","Weka RF descriptors regression","0.8925382081090829","0.7901234745345573","yes","0.68692850097922"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Tanimoto Smile SVM regression","0.5143911708105526","0.7454703038405649","yes","0.38088334172286736"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","RBF libSVM folded fingerprints regression","0.5226533918513468","0.7336796018011206","yes","0.38596829710863634"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Elastic Net on folded fingerprints regression","0.5302555305917452","0.7284893287676123","yes","0.3905469192985537"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Weka RF folded fingerprints regression","0.5347413795904102","0.726304354442175","yes","0.3963679792402572"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Poly Smile SVM fingerprints regression","0.5575640577121304","0.6891243759692409","yes","0.4079611120419108"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","Weka RF descriptors regression","0.6151549016435122","0.5957970586648713","yes","0.436770940166346"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","181","RBF Smile SVM descriptors regression","0.6950806149043683","0.48575560132795276","yes","0.5034278159905268"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","RBF libSVM folded fingerprints regression","0.6232453630818723","0.8085937140622893","yes","0.47153857373045016"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Tanimoto Smile SVM regression","0.6603635977050731","0.7870729120155845","yes","0.5088654687412053"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Elastic Net on folded fingerprints regression","0.6558521510381884","0.7812795576019488","yes","0.4971415550679209"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Poly Smile SVM fingerprints regression","0.6596403560652203","0.7745490825920942","yes","0.5015282963401053"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Weka RF folded fingerprints regression","0.7566148630132113","0.6908288475555968","yes","0.5619256360984609"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","RBF Smile SVM descriptors regression","0.9120740192388239","0.5177009205474371","yes","0.6887383807642924"
"WEE1","Activity Value","Assay Description:Inhibition of human Wee1 in presence of 9.5 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_003381, SK391, P30291, Q6NSL2|Standard Unit:nM","103","Weka RF descriptors regression","0.9638067727962262","0.40979221182458025","yes","0.7572537732734715"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Elastic Net on folded fingerprints regression","0.47041837791280305","0.7989237949700297","yes","0.3182316710900986"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Poly Smile SVM fingerprints regression","0.47093533217406874","0.7945588889580686","yes","0.31429363754163736"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","RBF libSVM folded fingerprints regression","0.47726647515622894","0.7894943118137832","yes","0.31589808001684044"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Weka RF folded fingerprints regression","0.48316006331439215","0.7835885824437758","yes","0.34942823651536686"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Tanimoto Smile SVM regression","0.48724069018857086","0.7758109162021911","yes","0.3323950197648005"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","RBF Smile SVM descriptors regression","0.6484057140723098","0.5860948216149753","yes","0.4492159930888469"
"DYRK1A","Activity Value","Assay Description:PubChem BioAssay. Assay for Inhibitors of Dual-Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase 1A (Kinase-Glo assay): round 2 SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1770, AID1970, AID2705, AID488872]|Activity Type:Potency|Target Accession Numbers:NP_001387, NP_567824, NP_569120, NP_569121, NP_569122, SK234, Q13627|Standard Unit:uM","141","Weka RF descriptors regression","0.641367057401849","0.5571048451269002","yes","0.46597626099456296"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Poly Smile SVM fingerprints regression","0.8433651989950265","0.7544129763686392","yes","0.5951301294171251"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","RBF libSVM folded fingerprints regression","0.8508751454770999","0.750198138802948","yes","0.5944076400379349"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Weka RF folded fingerprints regression","0.8829909121091069","0.7279844434335039","yes","0.6230539074579157"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Tanimoto Smile SVM regression","0.90211365722433","0.7162742913429467","yes","0.6343273004902802"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Elastic Net on folded fingerprints regression","0.9264138764356079","0.7031685909099539","yes","0.6457672477354574"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","Weka RF descriptors regression","0.9474700013741489","0.6777372674829528","yes","0.6757903210995526"
"LCK","Activity Value","Assay Description:Inhibition of LCK|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","243","RBF Smile SVM descriptors regression","0.9712620078029269","0.6703431775540347","yes","0.6688543374540532"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","RBF libSVM folded fingerprints regression","0.870335953087983","0.7764712431068709","yes","0.6532184555496727"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Poly Smile SVM fingerprints regression","0.8706195401648257","0.7753935759851214","yes","0.669633314573305"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Tanimoto Smile SVM regression","0.8778266016429922","0.7701145715413387","yes","0.6643298825396186"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Elastic Net on folded fingerprints regression","0.8862931339073162","0.7668910413521215","yes","0.6715808941450628"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Weka RF folded fingerprints regression","0.8852340857684892","0.765778668206642","yes","0.6906670298597036"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","RBF Smile SVM descriptors regression","0.9717101999620558","0.7164041552835726","yes","0.7297905108948443"
"LCK","Activity Value","Assay Description:Inhibition of Lck|Activity Type:IC50|Target Accession Numbers:NP_005347, SK206, P06239, Q7RTZ3|Standard Unit:nM","356","Weka RF descriptors regression","0.9963520839763212","0.6903260549777935","yes","0.7821768831500533"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Elastic Net on folded fingerprints regression","0.49530035221425794","0.8357376941555111","yes","0.3540831282006992"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Poly Smile SVM fingerprints regression","0.5021440579076402","0.8305118458038377","yes","0.3785890387655373"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","RBF libSVM folded fingerprints regression","0.502461877683337","0.8301367288013562","yes","0.37295464555421753"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Tanimoto Smile SVM regression","0.5436181863025895","0.7978717819089904","yes","0.41350048755890884"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Weka RF folded fingerprints regression","0.5715942073053087","0.7817362394673188","yes","0.44350854114087185"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","RBF Smile SVM descriptors regression","0.7172796225693149","0.6482458049411718","yes","0.4906632542784973"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. Confirmation Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1379, AID1770, AID1983, AID1997, AID2710, AID488872, AID488883, AID488887, AID493206, AID504421, AID504424, AID504427, AID504428, AID504429, AID504430]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:uM","167","Weka RF descriptors regression","0.7491736683727254","0.5598228829096298","yes","0.5718158323801629"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","RBF libSVM folded fingerprints regression","0.33039213893073754","0.7793981602062807","yes","0.24414660601387195"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Elastic Net on folded fingerprints regression","0.32887387115565786","0.778925194057308","yes","0.23433078247870368"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Weka RF folded fingerprints regression","0.34035786332667317","0.7674813003221574","yes","0.24392688396677323"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Tanimoto Smile SVM regression","0.3429246373092869","0.7557293095851998","yes","0.24926385986832242"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Poly Smile SVM fingerprints regression","0.3497226149422513","0.7506274466827116","yes","0.26032475254734583"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","RBF Smile SVM descriptors regression","0.4353609738953066","0.585203220180347","yes","0.31606838310592794"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (Kinase-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","558","Weka RF descriptors regression","0.47606196520239286","0.42096630407536584","yes","0.3389012474601263"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","RBF libSVM folded fingerprints regression","0.316598841755972","0.7949479488185055","yes","0.2298071055077359"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Elastic Net on folded fingerprints regression","0.3270253628118353","0.7757158946297534","yes","0.23434018310930588"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Tanimoto Smile SVM regression","0.32712370391304","0.7750886915468834","yes","0.23432105521647903"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Weka RF folded fingerprints regression","0.33563203047289797","0.7743543150898309","yes","0.24640055614499615"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Poly Smile SVM fingerprints regression","0.34338201299365917","0.7617595511474253","yes","0.2482410134621379"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","RBF Smile SVM descriptors regression","0.41675532851750846","0.6064019329436408","yes","0.3023756758515898"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-Glo Assay). (Class of assay: confirmatory) [Related pubchem assays: 1379 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","605","Weka RF descriptors regression","0.4609922483633936","0.4549413314339646","yes","0.3385236086851525"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Elastic Net on folded fingerprints regression","0.39852959443142283","0.7695588785646206","yes","0.2823615896834948"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","RBF libSVM folded fingerprints regression","0.4031385970190024","0.7691369247593038","yes","0.295925647197264"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Weka RF folded fingerprints regression","0.4258078663780963","0.744601302406007","yes","0.3137912823263864"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Poly Smile SVM fingerprints regression","0.4309236908827062","0.7337377446000662","yes","0.31626359758724043"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Tanimoto Smile SVM regression","0.4340588149064224","0.7219242583071707","yes","0.3233076200133745"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","RBF Smile SVM descriptors regression","0.5360503006564008","0.5492351910243628","yes","0.3856086765479099"
"CLK4","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of CDC-like Kinase 4 (ADP-FP Assay). (Class of assay: confirmatory) [Related pubchem assays: 1771 , 1770 ]|Activity Type:Potency|Target Accession Numbers:NP_065717_1, Q9HAZ1|Standard Unit:nM","364","Weka RF descriptors regression","0.5644248782772906","0.42762246043337215","yes","0.4017261504851767"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","RBF libSVM folded fingerprints regression","0.7164856809696811","0.6742975395823301","yes","0.5294772334054534"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Poly Smile SVM fingerprints regression","0.7187255145852359","0.6721597500721659","yes","0.5297964982850193"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Elastic Net on folded fingerprints regression","0.7202583792279877","0.6681653039207364","yes","0.5092024794987869"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Tanimoto Smile SVM regression","0.7429709714716338","0.6399830028793281","yes","0.5413362283157764"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Weka RF folded fingerprints regression","0.762255592584152","0.6223389612075222","yes","0.5473386939721809"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","RBF Smile SVM descriptors regression","0.7845873213780366","0.5887411123263169","yes","0.5858001154923347"
"CDK4","Activity Value","Assay Description:Inhibition of Cyclin-dependent kinase 4-cyclin D1|Activity Type:IC50|Target Accession Numbers:NP_000066, SK069, P11802, Q6FG61|Standard Unit:nM","115","Weka RF descriptors regression","0.827580190952407","0.5288158940890607","yes","0.626009427703102"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","RBF libSVM folded fingerprints regression","0.7342999597676714","0.7716923928936136","yes","0.5218655869089626"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Tanimoto Smile SVM regression","0.7508925988781783","0.7589089506356382","yes","0.5378898952765232"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Elastic Net on folded fingerprints regression","0.7565095378768986","0.7564924224951217","yes","0.5454248042319652"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Poly Smile SVM fingerprints regression","0.7724371120562595","0.7430809413239015","yes","0.5581627810931857"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Weka RF folded fingerprints regression","0.7898703667803352","0.7392458282350587","yes","0.5789872093572123"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","Weka RF descriptors regression","0.8316159034852368","0.696389864093653","yes","0.5945429568998278"
"SRC","Activity Value","Assay Description:Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","171","RBF Smile SVM descriptors regression","0.8608287497430462","0.6782707818581876","yes","0.6273472868608047"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","RBF libSVM folded fingerprints regression","0.7723867831804553","0.8744216884959785","yes","0.48728079632342797"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Poly Smile SVM fingerprints regression","0.7913647610513174","0.8687995324064716","yes","0.5158180751203122"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Elastic Net on folded fingerprints regression","0.8216843112335844","0.855739641750477","yes","0.5180017722233188"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Tanimoto Smile SVM regression","0.825684064020011","0.8545799037119205","yes","0.5297570557925094"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Weka RF folded fingerprints regression","0.8460698692808469","0.8477716097951021","yes","0.5600014300551618"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","RBF Smile SVM descriptors regression","0.8592162884708147","0.8416883872163784","yes","0.5776989824884894"
"SRC","Activity Value","Assay Description:Inhibition of Src|Activity Type:IC50|Target Accession Numbers:NP_005408, NP_938033, SK357, P12931, Q76P87_HUMAN_1|Standard Unit:nM","227","Weka RF descriptors regression","0.9226638000012342","0.8181297373445973","yes","0.6245262378076912"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","RBF libSVM folded fingerprints regression","0.8153313003452247","0.7053645867830717","yes","0.6578533348432282"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Poly Smile SVM fingerprints regression","0.8413030044840998","0.6863063063353436","yes","0.6844753113793456"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Tanimoto Smile SVM regression","0.8413496414919832","0.6800690222120507","yes","0.6737863680438854"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Elastic Net on folded fingerprints regression","0.8663943307035726","0.6647005159478736","yes","0.6667269274304066"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Weka RF folded fingerprints regression","0.8625949042272216","0.660610855315604","yes","0.7151319773931246"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","RBF Smile SVM descriptors regression","0.94882407188146","0.5882775451175394","yes","0.7379664191042424"
"VEGFR2","Activity Value","Assay Description:Inhibition of recombinant VEGFR2 by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","169","Weka RF descriptors regression","0.9561135572782646","0.5529628703160128","yes","0.7593177183692792"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","RBF libSVM folded fingerprints regression","0.7604496595684579","0.826754936818312","yes","0.5492490201578013"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Poly Smile SVM fingerprints regression","0.7645901128564111","0.8246572601528672","yes","0.5577909615485676"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Tanimoto Smile SVM regression","0.790693616988562","0.8111459976330602","yes","0.5717511143479835"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Weka RF folded fingerprints regression","0.815062679666376","0.8048508746369597","yes","0.6218371403412271"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Elastic Net on folded fingerprints regression","0.8170981025934796","0.7979090029389755","yes","0.5929564222657701"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","RBF Smile SVM descriptors regression","0.9056108730783206","0.74500499458117","yes","0.6707506884093171"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","473","Weka RF descriptors regression","0.9175081159205263","0.7448069937919337","yes","0.7123209020090971"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Poly Smile SVM fingerprints regression","0.8218397831081377","0.8140239856371961","yes","0.612082889424823"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Tanimoto Smile SVM regression","0.8228600424283483","0.8130705188487876","yes","0.6051728042480933"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","RBF libSVM folded fingerprints regression","0.8362884783849404","0.8080085491995062","yes","0.62034584353305"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Weka RF folded fingerprints regression","0.8401103272143506","0.8039934557788401","yes","0.6503967913486373"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","RBF Smile SVM descriptors regression","0.8655632443712062","0.7943003973964607","yes","0.6402349383316237"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Weka RF descriptors regression","0.879067498494579","0.7828600889999671","yes","0.696046534858339"
"VEGFR2","Activity Value","Assay Description:Inhibition of KDR by HTRF assay|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","365","Elastic Net on folded fingerprints regression","0.8949192972551139","0.7782308121018094","yes","0.6708447828558499"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Tanimoto Smile SVM regression","0.7442855951677629","0.8233570409599948","yes","0.5331911217886774"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Poly Smile SVM fingerprints regression","0.7683595006182363","0.8097029437465914","yes","0.5535296965596883"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","RBF libSVM folded fingerprints regression","0.7735867313602167","0.806808260794289","yes","0.5529062464266512"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Weka RF folded fingerprints regression","0.7930967521724215","0.8024130758842082","yes","0.5816444886131227"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","RBF Smile SVM descriptors regression","0.8065826504344362","0.7891115478083724","yes","0.5776966678767268"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Weka RF descriptors regression","0.8693392463498689","0.7597538471260544","yes","0.6515389257165732"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","428","Elastic Net on folded fingerprints regression","0.8774958195925874","0.7462375176233004","yes","0.6270201982956518"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Tanimoto Smile SVM regression","0.751141146291967","0.8131383919368244","yes","0.5491628146501628"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","RBF libSVM folded fingerprints regression","0.7622860734918592","0.8059294499283176","yes","0.5508767703298275"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Poly Smile SVM fingerprints regression","0.763736194636728","0.8058509282968002","yes","0.5542296447476343"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","RBF Smile SVM descriptors regression","0.8037086222216531","0.7822192429930406","yes","0.597264960946895"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Weka RF folded fingerprints regression","0.8157190197006996","0.7811179412007279","yes","0.5995402965525355"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Elastic Net on folded fingerprints regression","0.8528614312203014","0.7517508233637953","yes","0.6238544954195888"
"VEGFR2","Activity Value","Assay Description:Inhibition of VEGFR2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","451","Weka RF descriptors regression","0.9055242653682033","0.7227257413762873","yes","0.6940617923189775"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","RBF Smile SVM descriptors regression","0.6197180443482968","0.8858105530641226","yes","0.5089318564642673"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Tanimoto Smile SVM regression","0.663750665413357","0.8675824330476355","yes","0.5265529353935008"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Weka RF descriptors regression","0.6681185921564659","0.8654807207977213","yes","0.5451872881159551"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Poly Smile SVM fingerprints regression","0.6760167252589452","0.8628130367901621","yes","0.5409428961326324"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","RBF libSVM folded fingerprints regression","0.6785524264977019","0.8625770171003745","yes","0.5399942589863579"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Weka RF folded fingerprints regression","0.6794106580395148","0.861416059908741","yes","0.5573739752197713"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Accession Numbers:NP_002244, SK402, P35968, Q59EB0|Standard Unit:nM","105","Elastic Net on folded fingerprints regression","0.7989419787051206","0.8030403421412972","yes","0.6253651894116525"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","RBF Smile SVM descriptors regression","0.6197180443482968","0.8858105530641226","yes","0.5089318564642673"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Tanimoto Smile SVM regression","0.663750665413357","0.8675824330476355","yes","0.5265529353935008"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Weka RF descriptors regression","0.6681185921564659","0.8654807207977213","yes","0.5451872881159551"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Poly Smile SVM fingerprints regression","0.6760167252589452","0.8628130367901621","yes","0.5409428961326324"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","RBF libSVM folded fingerprints regression","0.6785524264977019","0.8625770171003745","yes","0.5399942589863579"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Weka RF folded fingerprints regression","0.6794106580395148","0.861416059908741","yes","0.5573739752197713"
"VEGFR2","Activity Value","Assay Description:Inhibition of vascular endothelial growth factor receptor 2|Activity Type:IC50|Target Name:VEGFR2|Standard Unit:nM","105","Elastic Net on folded fingerprints regression","0.7989419787051206","0.8030403421412972","yes","0.6253651894116525"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Tanimoto Smile SVM regression","0.9969133237035301","0.7019046602751686","yes","0.7640016962468283"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","RBF libSVM folded fingerprints regression","1.0289632409258038","0.6770193153980861","yes","0.7610931173144476"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Elastic Net on folded fingerprints regression","1.0604916230890395","0.6645321557516618","yes","0.8153994896874708"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Poly Smile SVM fingerprints regression","1.073382442320219","0.6475003557772487","yes","0.7934797830773304"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","RBF Smile SVM descriptors regression","1.0706769560570284","0.6469142402619025","yes","0.8179047453519479"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Weka RF folded fingerprints regression","1.098790890144253","0.6220935656627876","yes","0.8402888495754224"
"FLT3","Activity Value","Assay Description:Inhibition of FLT3|Activity Type:IC50|Target Accession Numbers:NP_004110, SK149, P36888|Standard Unit:nM","106","Weka RF descriptors regression","1.1236465155151734","0.5963655988136416","yes","0.9155443198988795"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","RBF libSVM folded fingerprints regression","0.7563762491396113","0.813153735837602","yes","0.5808633708853871"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","RBF Smile SVM descriptors regression","0.7644728925233133","0.8100815488247093","yes","0.5612087636853934"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Poly Smile SVM fingerprints regression","0.7704360637843078","0.8074962808561885","yes","0.5937924213079571"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Tanimoto Smile SVM regression","0.7864519119948927","0.7964172537425698","yes","0.5726534176340909"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Weka RF descriptors regression","0.8192113280255371","0.7901925837814814","yes","0.6334266858743673"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Elastic Net on folded fingerprints regression","0.8609178789070554","0.7525206949408574","yes","0.6347630585734093"
"AKT1","Activity Value","Assay Description:Inhibition of Akt1|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","135","Weka RF folded fingerprints regression","0.9313326459001465","0.7248108087135785","yes","0.6853472826507245"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","RBF libSVM folded fingerprints regression","0.7659000058554327","0.8428515000527645","yes","0.5990836266985703"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Poly Smile SVM fingerprints regression","0.7842880804078","0.8352965225560675","yes","0.6257508069529458"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Weka RF folded fingerprints regression","0.8363975883124284","0.8148561997475374","yes","0.6598565635621282"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Elastic Net on folded fingerprints regression","0.8208238580143264","0.8143004872161584","yes","0.6507022424710281"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Tanimoto Smile SVM regression","0.8740161969466166","0.7896984656127413","yes","0.6787712768488926"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","Weka RF descriptors regression","0.8887672524776534","0.7833472429818751","yes","0.6970713947752812"
"AKT1","Activity Value","Assay Description:Inhibition of Akt|Activity Type:IC50|Target Accession Numbers:NP_001014431, NP_001014432, NP_005154, SK018, P31749|Standard Unit:nM","152","RBF Smile SVM descriptors regression","0.9155537984373869","0.7670597028999435","yes","0.6953468714280647"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","RBF Smile SVM descriptors regression","0.22912499698277689","0.8635197387958478","yes","0.17326593820196146"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Weka RF folded fingerprints regression","0.23987929577913422","0.852688723033538","yes","0.16788398358516454"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Tanimoto Smile SVM regression","0.25813112210833544","0.8221254787274777","yes","0.1769403588057335"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","RBF libSVM folded fingerprints regression","0.2610813833144456","0.8185230639661805","yes","0.17628116809570396"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Weka RF descriptors regression","0.266873946935798","0.8083159098015915","yes","0.18669608192762208"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Elastic Net on folded fingerprints regression","0.26846396391690674","0.8057791222801381","yes","0.17104281015912867"
"CDK5","Activity Value","Assay Description:Inhibition of human cdk5/p25 by SPA|Activity Type:IC50|Target Accession Numbers:NP_004926, SK070, Q00535|Standard Unit:nM","124","Poly Smile SVM fingerprints regression","0.3412035246869294","0.7434426488005512","yes","0.2423661946965717"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Weka RF folded fingerprints regression","0.4747158129250739","0.6128649638061621","yes","0.37338805433747235"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Tanimoto Smile SVM regression","0.49433151031720535","0.5700172081658431","yes","0.3828459839575428"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Weka RF descriptors regression","0.5067682375283666","0.5369298598733918","yes","0.39549933595046516"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Poly Smile SVM fingerprints regression","0.5136977372982947","0.5186338627588645","yes","0.41658089679177013"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","RBF libSVM folded fingerprints regression","0.515973897006274","0.5157193774259754","yes","0.40963042218003365"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","Elastic Net on folded fingerprints regression","0.5286125639381908","0.5124939475804237","yes","0.4008393139887823"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1 by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","114","RBF Smile SVM descriptors regression","0.5779627953876149","0.3918137279728417","yes","0.42435108370611285"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","RBF libSVM folded fingerprints regression","0.5900496790913135","0.80426590322512","yes","0.48915960512468043"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Poly Smile SVM fingerprints regression","0.6087409299637131","0.7902885281660038","yes","0.5016050398364577"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Weka RF folded fingerprints regression","0.6342587246053122","0.7763863927233743","yes","0.5121402505502428"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Elastic Net on folded fingerprints regression","0.6463235058911814","0.7691224765336486","yes","0.5178703950522321"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Tanimoto Smile SVM regression","0.6471618110482821","0.760512120313773","yes","0.5210661560632359"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","RBF Smile SVM descriptors regression","0.7241556890598297","0.6942041350299769","yes","0.5417542494573552"
"JNK1","Activity Value","Assay Description:Inhibition of recombinant JNK1 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","115","Weka RF descriptors regression","0.737784919774565","0.6751900383677794","yes","0.5907083611049465"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Elastic Net on folded fingerprints regression","0.7331809902124203","0.7183644261533563","yes","0.5707567946863069"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Poly Smile SVM fingerprints regression","0.743645248551323","0.7068900731345086","yes","0.5756428933741157"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","RBF libSVM folded fingerprints regression","0.745758651744883","0.7040946584969874","yes","0.5628245651336382"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Weka RF folded fingerprints regression","0.75599633190509","0.6977443642082576","yes","0.5912202692563835"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Weka RF descriptors regression","0.780421399063796","0.6701786860506646","yes","0.6113011085287093"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","RBF Smile SVM descriptors regression","0.7947033122840799","0.6678249004235555","yes","0.6120879911717032"
"JNK1","Activity Value","Assay Description:Inhibition of JNK1|Activity Type:IC50|Target Accession Numbers:NP_002741, NP_620637, SK188, P45983|Standard Unit:nM","143","Tanimoto Smile SVM regression","0.7990072559352709","0.657008635055953","yes","0.5927626036260993"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Tanimoto Smile SVM regression","0.7361772067929905","0.7973294252202596","yes","0.48176617915291586"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","RBF libSVM folded fingerprints regression","0.7534273736629776","0.7877822993081672","yes","0.46564076519750214"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Poly Smile SVM fingerprints regression","0.770425142389446","0.7759448845879711","yes","0.484067776922779"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Weka RF folded fingerprints regression","0.7894742673957095","0.7723182628740035","yes","0.47785887211000955"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","RBF Smile SVM descriptors regression","0.7721739602717347","0.7702600919408965","yes","0.519120495669332"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Elastic Net on folded fingerprints regression","0.8503188106349867","0.7204090442937676","yes","0.5189765967566398"
"AURb","Activity Value","Assay Description:Inhibition of Aurora B|Activity Type:IC50|Target Accession Numbers:NP_004208, SK406, Q96GD4|Standard Unit:nM","132","Weka RF descriptors regression","0.8604128219996439","0.7097272641050202","yes","0.5522707678995651"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Elastic Net on folded fingerprints regression","0.538452911826038","0.901162716996319","yes","0.4090754283828"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","RBF libSVM folded fingerprints regression","0.5898806771015642","0.8871251705826939","yes","0.4429752463412373"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Poly Smile SVM fingerprints regression","0.6044005393774237","0.8794358785784222","yes","0.46056975974379316"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Tanimoto Smile SVM regression","0.6271349204642231","0.8683774493520012","yes","0.461444041377883"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Weka RF folded fingerprints regression","0.6944113629319749","0.8387069379211876","yes","0.524458569837372"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","RBF Smile SVM descriptors regression","0.7840300658068746","0.7756949533578448","yes","0.6036526536936863"
"PKCt","Activity Value","Assay Description:Inhibition of PKCtheta|Activity Type:IC50|Target Accession Numbers:NP_006248, SK310, Q04759, Q3MJF1, Q5JUN8|Standard Unit:nM","119","Weka RF descriptors regression","0.8784970925476416","0.7070339536967211","yes","0.6705231075914662"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","RBF libSVM folded fingerprints regression","0.695482871511317","0.7526099868742495","yes","0.49588244852847013"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Elastic Net on folded fingerprints regression","0.7193265211175008","0.7340148602388366","yes","0.5305873989093521"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Poly Smile SVM fingerprints regression","0.7205264557509891","0.7339702027362577","yes","0.5176463863382404"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Weka RF folded fingerprints regression","0.7460904071980327","0.7190715197660624","yes","0.5655416742834937"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Tanimoto Smile SVM regression","0.7350449128816247","0.7165651234178348","yes","0.5345609059423122"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","Weka RF descriptors regression","0.7798030415758165","0.6788045749545929","yes","0.5972490270470464"
"ABL1","Activity Value","Assay Description:Inhibition of recombinant c-Abl by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_005148, NP_009297, SK006, P00519, Q45F09, Q59FK4|Standard Unit:nM","171","RBF Smile SVM descriptors regression","0.8492504837687481","0.6197930346010949","yes","0.6492155889475768"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Poly Smile SVM fingerprints regression","0.6656675614087363","0.83497258037638","yes","0.5430342498595359"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","RBF libSVM folded fingerprints regression","0.6648516951226833","0.8346722042330113","yes","0.5336927229601692"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Tanimoto Smile SVM regression","0.7080740801216503","0.8134793678763489","yes","0.5542584583472667"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Weka RF folded fingerprints regression","0.7096353533421071","0.8108835429190501","yes","0.5782585731600063"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Elastic Net on folded fingerprints regression","0.7356991943284865","0.7994021680743765","yes","0.5968984785376417"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","RBF Smile SVM descriptors regression","0.7743188353240689","0.7710694729439058","yes","0.6005145313304641"
"ITK","Activity Value","Assay Description:Inhibition of Itk|Activity Type:IC50|Target Accession Numbers:NP_005537, SK184, Q08881, Q32ML7|Standard Unit:nM","103","Weka RF descriptors regression","0.8225396087707054","0.7326002457976508","yes","0.6621980525551625"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Tanimoto Smile SVM regression","0.8090000204860537","0.5219020330847381","yes","0.57685115994341"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","RBF libSVM folded fingerprints regression","0.8156584977032558","0.5157077770676095","yes","0.5794222253088268"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Weka RF folded fingerprints regression","0.8068913659152244","0.5089924743116337","yes","0.6057702115434812"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Poly Smile SVM fingerprints regression","0.8273212131987095","0.5061907523002542","yes","0.599669860569555"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","RBF Smile SVM descriptors regression","0.8798638025213499","0.44915248859255386","yes","0.6305272107423556"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Elastic Net on folded fingerprints regression","0.895146875348905","0.42967266062352266","yes","0.6137924879198196"
"EGFR","Value","Assay Description:Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","170","Weka RF descriptors regression","0.8663846384830924","0.3947305014548849","yes","0.6505849980422467"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Tanimoto Smile SVM regression","0.7486108084724383","0.8627828222277069","yes","0.546787583348301"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","RBF libSVM folded fingerprints regression","0.7612656172520311","0.8582805977820394","yes","0.5387622508056422"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Poly Smile SVM fingerprints regression","0.771396556086564","0.8536648136613597","yes","0.5426552379923422"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Weka RF folded fingerprints regression","0.792434529594145","0.8514144544588058","yes","0.5933627333773905"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Elastic Net on folded fingerprints regression","0.809398895627204","0.8382538691439926","yes","0.5803590656269348"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","RBF Smile SVM descriptors regression","0.8507668600206229","0.8186270223002398","yes","0.6191241191817414"
"EGFR","Value","Assay Description:Inhibition of EGFR|Activity type:IC50|Target Description:epidermal growth factor receptor isoform a|Standard unit:nM","506","Weka RF descriptors regression","0.9295685180779727","0.7871035255550507","yes","0.710328407663096"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Tanimoto Smile SVM regression","0.5978928789151005","0.7144683919256108","yes","0.4605704659103721"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","RBF libSVM folded fingerprints regression","0.6026113181669053","0.6999949908741969","yes","0.46221331329560217"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Poly Smile SVM fingerprints regression","0.6323833020579311","0.6581938836568009","yes","0.4833352087791484"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Weka RF folded fingerprints regression","0.656534923450611","0.6456932240834632","yes","0.49115776516841725"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Elastic Net on folded fingerprints regression","0.6698249726786484","0.6108151083944448","yes","0.5037845224573473"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","RBF Smile SVM descriptors regression","0.7233888759993157","0.5078805740724724","yes","0.5487974772712119"
"TGFbR1","Activity Value","Assay Description:Inhibition of TGFR1|Activity Type:IC50|Target Accession Numbers:NP_004603, SK029, P36897, Q5T7S2, Q6IR47|Standard Unit:nM","104","Weka RF descriptors regression","0.7329926317051577","0.47551357443905","yes","0.5465487236006381"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Poly Smile SVM fingerprints regression","0.5804901400155837","0.885148313871339","yes","0.3885174742519815"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","RBF libSVM folded fingerprints regression","0.5888614666765849","0.8803009761878312","yes","0.38089665032292863"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Elastic Net on folded fingerprints regression","0.6147888339098398","0.8656217876828771","yes","0.3811936922095317"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Tanimoto Smile SVM regression","0.6474982680408136","0.8492881724963687","yes","0.4213596937297373"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Weka RF folded fingerprints regression","0.6644556739930612","0.8403494119062096","yes","0.4163945875434246"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","Weka RF descriptors regression","0.6724540610625416","0.8386167599859994","yes","0.4865268423008859"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Accession Numbers:NP_002728, SK3003, P17252, Q32M72|Standard Unit:nM","103","RBF Smile SVM descriptors regression","0.6898603478475175","0.8275209244503263","yes","0.48373663074410667"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","RBF libSVM folded fingerprints regression","0.6380246797969799","0.8760516501722757","yes","0.43201611424884245"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Poly Smile SVM fingerprints regression","0.6728730666437356","0.8614275826648652","yes","0.47228086839752076"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Weka RF folded fingerprints regression","0.6695514449009405","0.852026968360868","yes","0.46528685775632167"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Elastic Net on folded fingerprints regression","0.6816511613962751","0.8488117443720142","yes","0.4793786495789769"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Tanimoto Smile SVM regression","0.6815122295097927","0.8438651985821674","yes","0.49010724496494956"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","Weka RF descriptors regression","0.7541247554774304","0.8048655058779974","yes","0.555890252957914"
"PKCa","Activity Value","Assay Description:Inhibition of Protein kinase C alpha|Activity Type:IC50|Target Name:PKCa|Standard Unit:nM","105","RBF Smile SVM descriptors regression","0.8043262733170865","0.7783254691268918","yes","0.5627503685119017"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","RBF Smile SVM descriptors regression","0.8241172840520831","0.5700904898550649","yes","0.6151342035195904"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Tanimoto Smile SVM regression","0.820721737891115","0.5487004270763544","yes","0.586663814442034"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","RBF libSVM folded fingerprints regression","0.8414401554204627","0.5260900410733333","yes","0.604961289513456"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Weka RF descriptors regression","0.8320360582940745","0.5215981092702545","yes","0.6347123719710627"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Poly Smile SVM fingerprints regression","0.8762006884161022","0.4843412494791639","yes","0.6449350363919242"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Weka RF folded fingerprints regression","0.8882836584700623","0.4336449910160858","yes","0.6835362567384048"
"EPHB4","Activity Value","Assay Description:Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_004435, SK130, P54760, Q541P7, Q59F17, Q7Z635, Q96L35|Standard Unit:nM","170","Elastic Net on folded fingerprints regression","0.9357113591263262","0.42162357641764964","yes","0.6604849958950035"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Tanimoto Smile SVM regression","0.7498868523149068","0.7455769584136416","yes","0.5440592800943588"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Elastic Net on folded fingerprints regression","0.8067894655794259","0.7040895350236738","yes","0.5715952214218607"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","RBF libSVM folded fingerprints regression","0.8103025897509444","0.6959382502920013","yes","0.5921437965557929"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Weka RF folded fingerprints regression","0.8230332987974628","0.6932392777672267","yes","0.6227251127623513"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Poly Smile SVM fingerprints regression","0.8241449887880984","0.6855686652990072","yes","0.6043040125092172"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","Weka RF descriptors regression","0.8636094260910939","0.6403491895436757","yes","0.6619013551047844"
"HCK","Activity Value","Assay Description:Inhibition of recombinant HCK by radioactive phosphotransfer assay in presence of 10 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_002101, SK164, P08631, Q504R5|Standard Unit:nM","171","RBF Smile SVM descriptors regression","0.8974240129334211","0.6319478415899084","yes","0.6696616152557202"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Elastic Net on folded fingerprints regression","0.35238563275965284","0.33975139917215536","yes","0.2681602856402968"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Poly Smile SVM fingerprints regression","0.3582529952987605","0.30825862886561356","yes","0.2762588153579566"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF folded fingerprints regression","0.3531211779437626","0.29717533587298034","yes","0.27096447127537315"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","RBF libSVM folded fingerprints regression","0.36836287055046607","0.2856451531706334","yes","0.2845877744912828"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","RBF Smile SVM descriptors regression","0.37673290265651405","0.2636268459881843","yes","0.2891531876147395"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Tanimoto Smile SVM regression","0.3688766541480271","0.25746612325864277","yes","0.28675643535243367"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF descriptors regression","0.36192003882620055","0.233870885142837","yes","0.2846146111619898"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Elastic Net on folded fingerprints regression","0.35238563275965284","0.33975139917215536","yes","0.2681602856402968"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Poly Smile SVM fingerprints regression","0.3582529952987605","0.30825862886561356","yes","0.2762588153579566"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF folded fingerprints regression","0.3531211779437626","0.29717533587298034","yes","0.27096447127537315"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","RBF libSVM folded fingerprints regression","0.36836287055046607","0.2856451531706334","yes","0.2845877744912828"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","RBF Smile SVM descriptors regression","0.37673290265651405","0.2636268459881843","yes","0.2891531876147395"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Tanimoto Smile SVM regression","0.3688766541480271","0.25746612325864277","yes","0.28675643535243367"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:nM","107","Weka RF descriptors regression","0.36192003882620055","0.233870885142837","yes","0.2846146111619898"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Elastic Net on folded fingerprints regression","0.35238563275965284","0.33975139917215536","yes","0.2681602856402968"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Poly Smile SVM fingerprints regression","0.3582529952987605","0.30825862886561356","yes","0.2762588153579566"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Weka RF folded fingerprints regression","0.3531211779437626","0.29717533587298034","yes","0.27096447127537315"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","RBF libSVM folded fingerprints regression","0.36836287055046607","0.2856451531706334","yes","0.2845877744912828"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","RBF Smile SVM descriptors regression","0.37673290265651405","0.2636268459881843","yes","0.2891531876147395"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Tanimoto Smile SVM regression","0.3688766541480271","0.25746612325864277","yes","0.28675643535243367"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Luminescent counterscreen for inhibitors of the Janus kinase 2 mutant JAK2V617F: dose response cell-based high throughput screening assay for inhibitors of parental Ba/F3 cell viability.. (Class of assay: confirmatory) [Related pubchem assays: 1446 (Primary screen.), 1486 (Counterscreen in triplicate.), 1691 (Dose response.)]|Activity Type:IC50|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:nM","107","Weka RF descriptors regression","0.36192003882620055","0.233870885142837","yes","0.2846146111619898"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Tanimoto Smile SVM regression","0.5950055531386237","0.38049712134297015","yes","0.4409915319470846"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","RBF libSVM folded fingerprints regression","0.6054634000318686","0.34559034618503853","yes","0.4547255369782865"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Poly Smile SVM fingerprints regression","0.606986885725781","0.31406884184725037","yes","0.4496655390317742"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Elastic Net on folded fingerprints regression","0.630819600258306","0.30420615919764377","yes","0.4674338591544067"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF folded fingerprints regression","0.6042412688701743","0.27953127428521113","yes","0.4494262455983106"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","RBF Smile SVM descriptors regression","0.6501829150852507","0.27697165557070885","yes","0.496751894190193"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF descriptors regression","0.6191329692939439","0.24239327386272427","yes","0.460556930307614"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Tanimoto Smile SVM regression","0.5950055531386237","0.38049712134297015","yes","0.4409915319470846"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","RBF libSVM folded fingerprints regression","0.6054634000318686","0.34559034618503853","yes","0.4547255369782865"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Poly Smile SVM fingerprints regression","0.606986885725781","0.31406884184725037","yes","0.4496655390317742"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Elastic Net on folded fingerprints regression","0.630819600258306","0.30420615919764377","yes","0.4674338591544067"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF folded fingerprints regression","0.6042412688701743","0.27953127428521113","yes","0.4494262455983106"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","RBF Smile SVM descriptors regression","0.6501829150852507","0.27697165557070885","yes","0.496751894190193"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","137","Weka RF descriptors regression","0.6191329692939439","0.24239327386272427","yes","0.460556930307614"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Tanimoto Smile SVM regression","0.5950055531386237","0.38049712134297015","yes","0.4409915319470846"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","RBF libSVM folded fingerprints regression","0.6054634000318686","0.34559034618503853","yes","0.4547255369782865"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Poly Smile SVM fingerprints regression","0.606986885725781","0.31406884184725037","yes","0.4496655390317742"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Elastic Net on folded fingerprints regression","0.630819600258306","0.30420615919764377","yes","0.4674338591544067"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Weka RF folded fingerprints regression","0.6042412688701743","0.27953127428521113","yes","0.4494262455983106"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","RBF Smile SVM descriptors regression","0.6501829150852507","0.27697165557070885","yes","0.496751894190193"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (Ba/F3 cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","137","Weka RF descriptors regression","0.6191329692939439","0.24239327386272427","yes","0.460556930307614"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF descriptors regression","0.5990570434932667","0.30964516827384114","yes","0.45071150423627465"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF folded fingerprints regression","0.6041646747731548","0.29546017636183397","yes","0.45129992494508964"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","RBF libSVM folded fingerprints regression","0.6273103256763018","0.2917663984077306","yes","0.46504517598782824"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Poly Smile SVM fingerprints regression","0.6192291286459992","0.27139162959232754","yes","0.4602996567849778"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","RBF Smile SVM descriptors regression","0.668740528533214","0.2633243893126371","yes","0.48139928102199614"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Tanimoto Smile SVM regression","0.6444994515645796","0.2632518020367604","yes","0.4884815237800115"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q506Q0_HUMAN, Q8IXP2_HUMAN|Standard Unit:um","164","Elastic Net on folded fingerprints regression","0.6516218637302742","0.21967483774830596","yes","0.47857486010237094"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF descriptors regression","0.5990570434932667","0.30964516827384114","yes","0.45071150423627465"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Weka RF folded fingerprints regression","0.6041646747731548","0.29546017636183397","yes","0.45129992494508964"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","RBF libSVM folded fingerprints regression","0.6273103256763018","0.2917663984077306","yes","0.46504517598782824"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Poly Smile SVM fingerprints regression","0.6192291286459992","0.27139162959232754","yes","0.4602996567849778"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","RBF Smile SVM descriptors regression","0.668740528533214","0.2633243893126371","yes","0.48139928102199614"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Tanimoto Smile SVM regression","0.6444994515645796","0.2632518020367604","yes","0.4884815237800115"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Accession Numbers:NP_004963, SK186, O60674, Q8IXP2_HUMAN|Standard Unit:um","164","Elastic Net on folded fingerprints regression","0.6516218637302742","0.21967483774830596","yes","0.47857486010237094"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Weka RF descriptors regression","0.5990570434932667","0.30964516827384114","yes","0.45071150423627465"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Weka RF folded fingerprints regression","0.6041646747731548","0.29546017636183397","yes","0.45129992494508964"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","RBF libSVM folded fingerprints regression","0.6273103256763018","0.2917663984077306","yes","0.46504517598782824"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Poly Smile SVM fingerprints regression","0.6192291286459992","0.27139162959232754","yes","0.4602996567849778"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","RBF Smile SVM descriptors regression","0.668740528533214","0.2633243893126371","yes","0.48139928102199614"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Tanimoto Smile SVM regression","0.6444994515645796","0.2632518020367604","yes","0.4884815237800115"
"JAK2","Activity Value","Assay Description:PubChem BioAssay. Late stage results from the probe development effort to identify inhibitors of the Janus kinase 2 mutant JAK2V617F.. (Class of assay: screening) [Related pubchem assays (depositor defined):AID1446, AID1486, AID1520, AID1521, AID1691, AID1699, AID1797] Panel member name: irf1 Inhibition (HEL cells)|Activity Type:Activity|Target Synonyms:JAK2, Janus kinase 2, Tyrosine protein kinase 2|Standard Unit:um","164","Elastic Net on folded fingerprints regression","0.6516218637302742","0.21967483774830596","yes","0.47857486010237094"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Weka RF folded fingerprints regression","0.7771077682304366","0.8319262759921874","yes","0.4417673867947535"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Poly Smile SVM fingerprints regression","0.8170425096906887","0.8061337799985171","yes","0.45414858254770524"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Tanimoto Smile SVM regression","0.8200176464507583","0.8045379960918112","yes","0.46126072929082107"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","RBF Smile SVM descriptors regression","0.8259222468490355","0.8014692060975731","yes","0.5104927477931188"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","RBF libSVM folded fingerprints regression","0.8416915737322542","0.7942945800713807","yes","0.45738309258515336"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Weka RF descriptors regression","0.8675975596217459","0.7814905614442108","yes","0.5559085938665346"
"Chk1","Activity Value","Assay Description:Inhibition of CHK1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","115","Elastic Net on folded fingerprints regression","0.9419505094870385","0.7481976667974233","yes","0.45786397457331385"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Tanimoto Smile SVM regression","0.7598961762573474","0.5644730266468716","yes","0.6151158431185656"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","RBF Smile SVM descriptors regression","0.9158143136580825","0.42415045815201513","yes","0.7206071907034857"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Weka RF descriptors regression","0.8561877446522386","0.4170807033020131","yes","0.7107724999322842"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Elastic Net on folded fingerprints regression","0.8785874433578229","0.4098336908590605","yes","0.6655249783649436"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Weka RF folded fingerprints regression","0.8571808295260477","0.3935827593213836","yes","0.6864697233469587"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","RBF libSVM folded fingerprints regression","0.8883627697895018","0.3839928601436073","yes","0.7119503843127241"
"Chk1","Activity Value","Assay Description:Inhibition at human Chk1 in presence of 4 uM ATP|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","103","Poly Smile SVM fingerprints regression","0.9644336090753864","0.30162190243949427","yes","0.7502521701155808"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Poly Smile SVM fingerprints regression","0.6808325630615946","0.8153840363152076","yes","0.5070792655919747"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","RBF libSVM folded fingerprints regression","0.695578269476586","0.8066244429742927","yes","0.5169739599789375"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Tanimoto Smile SVM regression","0.7216340996456538","0.79024503330271","yes","0.5335006026501711"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Weka RF folded fingerprints regression","0.7522796868867382","0.781042102318275","yes","0.5434631094157526"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Elastic Net on folded fingerprints regression","0.7615846188702607","0.7665761556092837","yes","0.5520832548035116"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","RBF Smile SVM descriptors regression","0.802667065506506","0.7363472878520262","yes","0.5907829805686421"
"Chk1","Activity Value","Assay Description:Inhibition of Chk1|Activity Type:IC50|Target Accession Numbers:NP_001265, SK078, O14757|Standard Unit:nM","291","Weka RF descriptors regression","0.8304318742503829","0.7181438736959115","yes","0.6059885185753282"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Tanimoto Smile SVM regression","0.7056800443575899","0.8582986687573523","yes","0.48452712087908995"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","RBF Smile SVM descriptors regression","0.7119720414354431","0.8550137265287113","yes","0.4912414335352621"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","RBF libSVM folded fingerprints regression","0.714836996226671","0.8538322737798459","yes","0.4819208718454265"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Elastic Net on folded fingerprints regression","0.7268683287808345","0.8488640824870526","yes","0.48039565153719316"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Poly Smile SVM fingerprints regression","0.7307318507877606","0.8465449911020352","yes","0.5001923063180812"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Weka RF folded fingerprints regression","0.7399105231510736","0.8444101432507656","yes","0.5123419553324595"
"AURa","Activity Value","Assay Description:Inhibition of Aurora A|Activity Type:IC50|Target Accession Numbers:NP_003591, NP_940835, NP_940836, NP_940837, NP_940838, NP_940839, SK407, O14965|Standard Unit:nM","330","Weka RF descriptors regression","0.7883816206068448","0.8230430923927616","yes","0.5623933064579085"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Tanimoto Smile SVM regression","0.9119334377524656","0.8045862580799564","yes","0.6823390416069391"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","RBF libSVM folded fingerprints regression","0.93395450742165","0.7922054048414786","yes","0.6989405988730367"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Weka RF folded fingerprints regression","0.954980345534119","0.7837934566113162","yes","0.723347972081245"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Poly Smile SVM fingerprints regression","0.9732860122642858","0.7717322670569563","yes","0.7413369038338316"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Elastic Net on folded fingerprints regression","1.0082981976324688","0.7563829807315424","yes","0.7562052291268777"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","Weka RF descriptors regression","1.0505280813010447","0.7356112927014778","yes","0.8516822074108845"
"HER2","Activity Value","Assay Description:Inhibition of HER2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","138","RBF Smile SVM descriptors regression","1.0471213214133357","0.7322395066909789","yes","0.8056301316936337"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Tanimoto Smile SVM regression","0.7652732925905652","0.4351213885128768","yes","0.5647180079835185"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Poly Smile SVM fingerprints regression","0.8001180412930072","0.42732753172184507","yes","0.6146693978709755"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Elastic Net on folded fingerprints regression","0.7962548510915938","0.4205018997004516","yes","0.5888744036474668"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","RBF libSVM folded fingerprints regression","0.8057286641386635","0.406308532289257","yes","0.6114781461759363"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Weka RF folded fingerprints regression","0.793530447569485","0.35422422212817994","yes","0.5934418517283816"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","RBF Smile SVM descriptors regression","0.8146551366635455","0.3465128517128897","yes","0.6207321097876851"
"HER2","Activity Value","Assay Description:Inhibition of ErbB2|Activity Type:IC50|Target Accession Numbers:NP_001005862, NP_004439, SK166, P04626|Standard Unit:nM","121","Weka RF descriptors regression","0.8500047863027408","0.2250071962273967","yes","0.631243516467006"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","RBF libSVM folded fingerprints regression","0.6571627445227638","0.7946432245076047","yes","0.5046165439302883"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Poly Smile SVM fingerprints regression","0.6750398509225458","0.7823234662567997","yes","0.5152231739401881"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Elastic Net on folded fingerprints regression","0.6829986213791509","0.7802794634972691","yes","0.5158740074986938"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Tanimoto Smile SVM regression","0.7260690089838163","0.7431523498778433","yes","0.5743406849357059"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Weka RF folded fingerprints regression","0.7697332660791859","0.7086106062009232","yes","0.6047894546744642"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","RBF Smile SVM descriptors regression","0.7772429794790249","0.7041809356368984","yes","0.6147793854540564"
"SYK","Activity Value","Assay Description:Inhibition of recombinant Syk|Activity Type:IC50|Target Accession Numbers:NP_003168, SK363, P43405, Q5T6N7, Q5T6N8|Standard Unit:nM","141","Weka RF descriptors regression","0.7838686231802229","0.6916047266605799","yes","0.6377329800163685"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","RBF libSVM folded fingerprints regression","0.4611162758873191","0.9073997400304079","yes","0.3688849503385863"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Poly Smile SVM fingerprints regression","0.46672081989037867","0.9068839932753441","yes","0.38698957396144634"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Tanimoto Smile SVM regression","0.47654983990514016","0.9030692297865622","yes","0.38898983412142124"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Weka RF folded fingerprints regression","0.49535422587912525","0.8953197000991834","yes","0.4055322320383073"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Elastic Net on folded fingerprints regression","0.4989372555984","0.8944015820645247","yes","0.40272508328735823"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","RBF Smile SVM descriptors regression","0.525090130442223","0.8793978285445313","yes","0.40437967607595365"
"JNK2","Activity Value","Assay Description:Inhibition of recombinant JNK2 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","117","Weka RF descriptors regression","0.602258344887517","0.8380376588522838","yes","0.49415128386444823"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Poly Smile SVM fingerprints regression","0.6339303450423086","0.9104380302814694","yes","0.41869904384289675"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","RBF libSVM folded fingerprints regression","0.6269795503097247","0.9101657873058391","yes","0.3936676711322605"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Elastic Net on folded fingerprints regression","0.6352336327894084","0.9075314025108131","yes","0.363891684495803"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Tanimoto Smile SVM regression","0.6583033873011711","0.9004161714181468","yes","0.407984696607032"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Weka RF folded fingerprints regression","0.6843110402127919","0.8928482528312353","yes","0.4274555739428278"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","RBF Smile SVM descriptors regression","0.6867102617445863","0.8914695782704136","yes","0.4221176919406358"
"JNK2","Activity Value","Assay Description:Inhibition of JNK2|Activity Type:IC50|Target Accession Numbers:SK189, P45984|Standard Unit:nM","130","Weka RF descriptors regression","0.7384003959981564","0.8733320772554353","yes","0.4736752192127372"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Weka RF descriptors regression","0.8455583825615104","0.15280555896341652","yes","0.5782247356500719"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Elastic Net on folded fingerprints regression","0.8387514612711668","0.14670143142386233","yes","0.5615324442120923"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Tanimoto Smile SVM regression","0.8614302706775865","0.14615890331443404","yes","0.5712964429188688"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Poly Smile SVM fingerprints regression","0.9230416159571669","0.1334803005671335","yes","0.6743536226564172"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","Weka RF folded fingerprints regression","0.8416087299658621","0.13204543360827242","yes","0.5504511105416091"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","RBF libSVM folded fingerprints regression","0.8870109011728111","0.09917903314016689","yes","0.5533596201973877"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory)|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","7167","RBF Smile SVM descriptors regression","0.8473209124178888","0.09320654713019245","yes","0.5904195383159053"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Tanimoto Smile SVM regression","0.4972208188310735","0.17857568883484906","yes","0.3447690733729487"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Poly Smile SVM fingerprints regression","0.5046749118559691","0.17343178719771674","yes","0.36019940708130815"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Weka RF descriptors regression","0.48432404711388","0.17291348940116674","yes","0.33136639252636696"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Weka RF folded fingerprints regression","0.4830702047116807","0.14973663395136408","yes","0.32062757155211996"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","Elastic Net on folded fingerprints regression","0.48196112137428143","0.14513205057023978","yes","0.3259092862461113"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","RBF libSVM folded fingerprints regression","0.5131025473451332","0.13299363576587894","yes","0.3430748594227615"
"ERK1","Activity Value","Assay Description:PubChem BioAssay. qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ]|Activity Type:Potency|Target Accession Numbers:NP_002736, NP_620407, SK135, P28482|Standard Unit:nM","6398","RBF Smile SVM descriptors regression","0.5025673344866728","0.09670540029633676","yes","0.3552605375887234"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","RBF libSVM folded fingerprints regression","0.8200033998168771","0.7637891690915579","yes","0.581862530906591"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Weka RF folded fingerprints regression","0.8394552406773972","0.7536557876739531","yes","0.6202315204310964"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Poly Smile SVM fingerprints regression","0.8356292069466269","0.7536278973624895","yes","0.6073870107932776"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Tanimoto Smile SVM regression","0.8524797236070469","0.7424943090827127","yes","0.601100537659528"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Weka RF descriptors regression","0.8758300650145401","0.7318456997210049","yes","0.6738925293389239"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","RBF Smile SVM descriptors regression","0.8979206491488031","0.716208116821742","yes","0.6752027443215661"
"CDK1","Activity Value","Assay Description:Inhibition of CDK1|Activity Type:IC50|Target Accession Numbers:NP_001777, SK065, P06493|Standard Unit:nM","248","Elastic Net on folded fingerprints regression","0.895222256307274","0.715114916565745","yes","0.6508648409836705"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","RBF libSVM folded fingerprints regression","0.6976854432487276","0.8621464579946336","yes","0.5286808152493263"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Poly Smile SVM fingerprints regression","0.7298129814114027","0.8482356642203839","yes","0.5509235279113527"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Tanimoto Smile SVM regression","0.7371276042019937","0.8462400297657712","yes","0.5300914693980421"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Weka RF folded fingerprints regression","0.7362935618393106","0.845343545713241","yes","0.5485640071306354"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Elastic Net on folded fingerprints regression","0.7763144730555835","0.827140687518854","yes","0.558649866965954"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","RBF Smile SVM descriptors regression","0.8400814320395483","0.7974491026673061","yes","0.6184450267681362"
"TIE2","Activity Value","Assay Description:Inhibition of Tie2|Activity Type:IC50|Target Accession Numbers:NP_000450, SK367, Q02763, Q59HG2, Q5TCU2|Standard Unit:nM","166","Weka RF descriptors regression","0.8425921933401579","0.7914257361040764","yes","0.619866696927491"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Tanimoto Smile SVM regression","0.6362303240492837","0.8432557465160128","yes","0.4280731204119675"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Weka RF folded fingerprints regression","0.6582455220009763","0.8391952127493952","yes","0.4711748090409972"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","RBF libSVM folded fingerprints regression","0.6378586954742331","0.8388779911060938","yes","0.4192707038008255"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Poly Smile SVM fingerprints regression","0.6512171722149651","0.8315383183824676","yes","0.43648922639130466"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Elastic Net on folded fingerprints regression","0.6936117448920123","0.807113925532494","yes","0.4728470988246178"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","RBF Smile SVM descriptors regression","0.6982884092611236","0.8049789284686204","yes","0.4815063819814044"
"IGF1R","Activity Value","Assay Description:Inhibition of IGF1R|Activity Type:IC50|Target Accession Numbers:NP_000866, SK174, P08069|Standard Unit:nM","221","Weka RF descriptors regression","0.7786670996565174","0.7492495262812259","yes","0.5337200871563937"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Tanimoto Smile SVM regression","0.6333762584440371","0.8725873611541172","yes","0.45887192133208343"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Weka RF descriptors regression","0.6935547120561512","0.8522463743142277","yes","0.5558952358507334"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Weka RF folded fingerprints regression","0.6806618854803693","0.8516780573088581","yes","0.4859611409583524"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","RBF libSVM folded fingerprints regression","0.6884419477682604","0.8463607073976067","yes","0.46984692439592723"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","RBF Smile SVM descriptors regression","0.6928529481578908","0.8462383557499337","yes","0.5034150053595423"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Poly Smile SVM fingerprints regression","0.7227651327131779","0.8286191246371607","yes","0.4937905026600808"
"PLK1","Activity Value","Assay Description:Inhibition of PLK1|Activity Type:IC50|Target Accession Numbers:NP_005021, P53350|Standard Unit:nM","133","Elastic Net on folded fingerprints regression","0.8207896591915255","0.7801357002913241","yes","0.5248936034214378"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Tanimoto Smile SVM regression","0.6051933977662726","0.8456311026696076","yes","0.4948906115253838"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","RBF libSVM folded fingerprints regression","0.623486380370136","0.8366705212540134","yes","0.4991645205611371"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Elastic Net on folded fingerprints regression","0.6742544331422665","0.8229681560211775","yes","0.5328730287032392"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Poly Smile SVM fingerprints regression","0.6625459324182169","0.8157342585158038","yes","0.5245437274090692"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Weka RF folded fingerprints regression","0.680358062166036","0.8087849632558277","yes","0.5380978781343378"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","RBF Smile SVM descriptors regression","0.6916356757656325","0.7939025950981352","yes","0.5270002340708885"
"JNK3","Activity Value","Assay Description:Inhibition of recombinant JNK3 after 60 mins by TR-FRET assay|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","121","Weka RF descriptors regression","0.6983292252495173","0.7916471583914381","yes","0.5678273029840699"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Poly Smile SVM fingerprints regression","0.391200748626621","0.48156812581489217","yes","0.3001603171062685"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","RBF libSVM folded fingerprints regression","0.4053357768759009","0.45326184373989453","yes","0.3135373191162311"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Tanimoto Smile SVM regression","0.40578570993954327","0.4442711658109444","yes","0.3114553791152743"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Weka RF folded fingerprints regression","0.3996734776465957","0.4365315554368987","yes","0.3058089086495818"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Elastic Net on folded fingerprints regression","0.41645304867739125","0.40746661730078443","yes","0.3149369509653762"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","RBF Smile SVM descriptors regression","0.4347883698819778","0.3950096490786026","yes","0.33626124478203445"
"JNK3","Activity Value","Assay Description:PubChem BioAssay. Dose response biochemical screening assay for inhibitors of c-Jun N-Terminal Kinase 3 (JNK3). (Class of assay: confirmatory) [Related pubchem assays: 746 ]|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","362","Weka RF descriptors regression","0.4192513998833311","0.3433329083843605","yes","0.32457321266522754"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Weka RF folded fingerprints regression","0.8094253817296261","0.8020556948289184","yes","0.6064832477864671"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Poly Smile SVM fingerprints regression","0.8204816798394531","0.7931069180185154","yes","0.6225580413573446"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","RBF libSVM folded fingerprints regression","0.8147207383854378","0.7924913274805008","yes","0.6028179429755485"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Elastic Net on folded fingerprints regression","0.8524378179484167","0.7702324217370501","yes","0.6204033094121807"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Tanimoto Smile SVM regression","0.8626760523359707","0.7636628445893552","yes","0.6277201227177593"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","RBF Smile SVM descriptors regression","0.9756968420288534","0.6969582792727618","yes","0.745446234527848"
"JNK3","Activity Value","Assay Description:Inhibition of JNK3|Activity Type:IC50|Target Accession Numbers:NP_002744, NP_620446, NP_620448, SK190, P53779, Q49AP1|Standard Unit:nM","122","Weka RF descriptors regression","0.9776848763604314","0.6870890295897085","yes","0.7511608511031099"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","RBF Smile SVM descriptors regression","0.5428189640521431","0.7791328452213238","yes","0.37083628072559044"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Tanimoto Smile SVM regression","0.5533514167020794","0.7640139041253271","yes","0.383189953358011"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Weka RF descriptors regression","0.5646443518103177","0.7541347874463541","yes","0.407124284192618"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Poly Smile SVM fingerprints regression","0.5607977149777762","0.7536127117067598","yes","0.39005291616697463"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","RBF libSVM folded fingerprints regression","0.5661455869364119","0.748450514374735","yes","0.39928986834787333"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Weka RF folded fingerprints regression","0.6059605521503197","0.7219055205952143","yes","0.42397616887860423"
"GSK3b","Activity Value","Assay Description:Inhibition of recombinant GSK3-beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","150","Elastic Net on folded fingerprints regression","0.6624313774084634","0.6374234122329594","yes","0.45222570845372456"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Poly Smile SVM fingerprints regression","0.9387829756194513","0.7267523815306299","yes","0.6326699714109253"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","RBF libSVM folded fingerprints regression","0.9338064945558585","0.7255318211632545","yes","0.6144026084486628"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Weka RF descriptors regression","0.994605944551423","0.6972442575997244","yes","0.6927008229357496"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","RBF Smile SVM descriptors regression","0.9732474794693742","0.6952568564360929","yes","0.7004505865879239"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Tanimoto Smile SVM regression","0.9790079393423727","0.6898656085936333","yes","0.6294814270256422"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Weka RF folded fingerprints regression","1.0282785768043297","0.6712608652259885","yes","0.6666286376660797"
"GSK3b","Activity Value","Assay Description:Inhibition of GSK3beta|Activity Type:IC50|Target Accession Numbers:SK163, P49841, Q6FI27|Standard Unit:nM","157","Elastic Net on folded fingerprints regression","1.0345104625326442","0.6506156057979113","yes","0.6710781806186743"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","RBF libSVM folded fingerprints regression","0.7478003943109176","0.8811288730417564","yes","0.5494046523850846"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Tanimoto Smile SVM regression","0.7545776739505519","0.8800608168168965","yes","0.5529803069557153"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Weka RF folded fingerprints regression","0.7879210677263229","0.8695592311564354","yes","0.5878914668456715"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Poly Smile SVM fingerprints regression","0.7879949726407164","0.8685302746651778","yes","0.5836639753617446"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","RBF Smile SVM descriptors regression","0.7944981446578909","0.8643513788213778","yes","0.5987491322967251"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Elastic Net on folded fingerprints regression","0.8057697447740538","0.8613988311994799","yes","0.6064859182415722"
"MK2","Activity Value","Assay Description:Inhibition of MK2|Activity Type:IC50|Target Accession Numbers:NP_004750, NP_116584, SK212, P49137, Q5SY30, Q5SY41|Standard Unit:nM","205","Weka RF descriptors regression","0.8373158226483041","0.8532939584308684","yes","0.6329706563918555"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","RBF libSVM folded fingerprints regression","0.6700796094113171","0.7922621532505423","yes","0.5400705185387317"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Poly Smile SVM fingerprints regression","0.6995126802748394","0.7719643977826733","yes","0.5543688855655577"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Weka RF folded fingerprints regression","0.708734529353675","0.7611374011025495","yes","0.574036465930886"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Tanimoto Smile SVM regression","0.7320937833186553","0.7472402093150121","yes","0.5876162335592484"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Elastic Net on folded fingerprints regression","0.7603898219817187","0.7238886200297425","yes","0.6081104484383344"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","Weka RF descriptors regression","0.8324344463882413","0.6562474479086182","yes","0.6784295344364513"
"IRAK4","Activity Value","Assay Description:Inhibition of IRAK4|Activity Type:IC50|Target Accession Numbers:Q9NWZ3, Q69FE1, Q69FE3|Standard Unit:nM","117","RBF Smile SVM descriptors regression","0.9091677151964613","0.6115929305297579","yes","0.739099695506388"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","RBF libSVM folded fingerprints regression","0.6588774785903561","0.8584400072955648","yes","0.4822752975255948"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Poly Smile SVM fingerprints regression","0.6630321613432352","0.8568246961740145","yes","0.49111564004867103"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Tanimoto Smile SVM regression","0.6792461235084667","0.8504047448083515","yes","0.4866590583009611"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Weka RF folded fingerprints regression","0.7276335319094065","0.8338775658988973","yes","0.5431348955112282"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","RBF Smile SVM descriptors regression","0.7262039692623645","0.8252732481556266","yes","0.5445960975025934"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Elastic Net on folded fingerprints regression","0.7314590457495804","0.8248842046244671","yes","0.5282337874662331"
"p38a","Activity Value","Assay Description:Inhibition of p38alpha|Activity Type:IC50|Target Accession Numbers:NP_620581, Q16539|Standard Unit:nM","639","Weka RF descriptors regression","0.8120394665192484","0.7816881093385025","yes","0.6007800770288028"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Tanimoto Smile SVM regression","0.5050658266086104","0.709076082727631","yes","0.3710352258989282"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","RBF libSVM folded fingerprints regression","0.5080255357833992","0.7058712682364667","yes","0.37390895308473304"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Elastic Net on folded fingerprints regression","0.5123683377560899","0.6963709012430636","yes","0.3691533359897396"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Poly Smile SVM fingerprints regression","0.5167936529637834","0.6923698248059407","yes","0.38163060485785066"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Weka RF folded fingerprints regression","0.5312517240665091","0.6921971441146963","yes","0.4184729638122174"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","RBF Smile SVM descriptors regression","0.6266649284238813","0.513826429852054","yes","0.47001236942540925"
"VEGFR1","Activity Value","Assay Description:Inhibition of VEGFR1 by HTRF assay|Activity type:IC50|Target Accession Numbers:NP_002010, SK150, P17948, Q59GQ9, Q5TAR1|Standard unit:nM","102","Weka RF descriptors regression","0.6583347102141479","0.4053292465070064","yes","0.5054473638972244"
